Alison Motsinger-Reif
Alison Motsinger-Reif
National Institute of Environmental Health Sciences
Verified email at
Cited by
Cited by
Estimation of the warfarin dose with clinical and pharmacogenetic data
TE Klein, RB Altman, N Eriksson, BF Gage, SE Kimmel, MT Lee, NA Limdi, ...
The New England journal of medicine 360 (8), 753, 2009
A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction
DR Velez, BC White, AA Motsinger, WS Bush, MD Ritchie, SM Williams, ...
Genetic Epidemiology: the Official Publication of the International Genetic …, 2007
Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
NA Limdi, M Wadelius, L Cavallari, N Eriksson, DC Crawford, MTM Lee, ...
Blood, The Journal of the American Society of Hematology 115 (18), 3827-3834, 2010
CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection
A Motsinger, DW Haas, AK Stanic, L Van Kaer, S Joyce, D Unutmaz
The Journal of experimental medicine 195 (7), 869-879, 2002
Auriculotherapy for pain management: a systematic review and meta-analysis of randomized controlled trials
GN Asher, DE Jonas, RR Coeytaux, AC Reilly, YL Loh, AA Motsinger-Reif, ...
The Journal of Alternative and Complementary Medicine 16 (10), 1097-1108, 2010
Shift work in nurses: contribution of phenotypes and genotypes to adaptation
KL Gamble, AA Motsinger-Reif, A Hida, HM Borsetti, SV Servick, ...
PloS one 6 (4), e18395, 2011
Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmacogenomics studies
AA Motsinger, MD Ritchie
Human genomics 2 (5), 318, 2006
Effect of CYP2B6, ABCB1, and CYP3A5 Polymorphisms on Efavirenz Pharmacokinetics and Treatment Response: An AIDS Clinical Trials Group Study
HJ Ribaudo, H Liu, M Schwab, E Schaeffeler, M Eichelbaum, ...
The Journal of infectious diseases 202 (5), 717-722, 2010
Genome-wide association studies in pharmacogenomics: successes and lessons
AA Motsinger-Reif, E Jorgenson, MV Relling, DL Kroetz, R Weinshilboum, ...
Pharmacogenetics and genomics 23 (8), 383, 2013
Metabolic network failures in Alzheimer's disease: A biochemical road map
JB Toledo, M Arnold, G Kastenmüller, R Chang, RA Baillie, X Han, ...
Alzheimer's & Dementia 13 (9), 965-984, 2017
Alterations in metabolic pathways and networks in Alzheimer’s disease
R Kaddurah-Daouk, H Zhu, S Sharma, M Bogdanov, SG Rozen, ...
Translational psychiatry 3 (4), e244-e244, 2013
Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity
MD Ritchie, DW Haas, AA Motsinger, JP Donahue, H Erdem, S Raffanti, ...
Clinical infectious diseases 43 (6), 779-782, 2006
Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation
D Darbar, AA Motsinger, MD Ritchie, JV Gainer, DM Roden
Heart Rhythm 4 (6), 743-749, 2007
Comparison of approaches for machine‐learning optimization of neural networks for detecting gene‐gene interactions in genetic epidemiology
AA Motsinger‐Reif, SM Dudek, LW Hahn, MD Ritchie
Genetic Epidemiology: The Official Publication of the International Genetic …, 2008
GPNN: Power studies and applications of a neural network method for detecting gene-gene interactions in studies of human disease
AA Motsinger, SL Lee, G Mellick, MD Ritchie
BMC bioinformatics 7 (1), 39, 2006
Characterization of conserved and nonconserved imprinted genes in swine
SR Bischoff, S Tsai, N Hardison, AA Motsinger-Reif, BA Freking, ...
Biology of reproduction 81 (5), 906-920, 2009
Gene profiling of canine B-cell lymphoma reveals germinal center and postgerminal center subtypes with different survival times, modeling human DLBCL
KL Richards, AA Motsinger-Reif, HW Chen, Y Fedoriw, C Fan, ...
Cancer research 73 (16), 5029-5039, 2013
CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel
DL Hertz, S Roy, AA Motsinger-Reif, A Drobish, LS Clark, HL McLeod, ...
Annals of oncology 24 (6), 1472-1478, 2013
CYP2C8* 3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel
DL Hertz, AA Motsinger-Reif, A Drobish, SJ Winham, HL McLeod, ...
Breast cancer research and treatment 134 (1), 401-410, 2012
Multifactor dimensionality reduction for detecting gene–gene and gene–environment interactions in pharmacogenomics studies
MD Ritchie, AA Motsinger
Future Medicine Ltd 6 (8), 823-834, 2005
The system can't perform the operation now. Try again later.
Articles 1–20